解决肥厚性心肌病症状和心理社会评估的差异

IF 2.1 Q3 PERIPHERAL VASCULAR DISEASE

International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-08-28 DOI:10.1016/j.ijcrp.2025.200504

Brijesh Sathian, Abdalla Fadul, Yasir Alabbas, Hanadi Al Hamad

{"title":"解决肥厚性心肌病症状和心理社会评估的差异","authors":"Brijesh Sathian, Abdalla Fadul, Yasir Alabbas, Hanadi Al Hamad","doi":"10.1016/j.ijcrp.2025.200504","DOIUrl":null,"url":null,"abstract":"<div><div>This correspondence critiques a 2025 study by Tsenov et al. on hypertrophic cardiomyopathy, highlighting discrepancies in reported symptom burden, psychological support, employment impact, diagnostic delays, activity restrictions, and medication tolerability. Recent evidence suggests improved outcomes with novel therapies and integrated care, challenging the study's conclusions. We advocate for reconciled analyses and future longitudinal studies to enhance patient-centered hypertrophic cardiomyopathy management.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"27 ","pages":"Article 200504"},"PeriodicalIF":2.1000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Addressing discrepancies in symptom and psychosocial assessments in hypertrophic cardiomyopathy\",\"authors\":\"Brijesh Sathian, Abdalla Fadul, Yasir Alabbas, Hanadi Al Hamad\",\"doi\":\"10.1016/j.ijcrp.2025.200504\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>This correspondence critiques a 2025 study by Tsenov et al. on hypertrophic cardiomyopathy, highlighting discrepancies in reported symptom burden, psychological support, employment impact, diagnostic delays, activity restrictions, and medication tolerability. Recent evidence suggests improved outcomes with novel therapies and integrated care, challenging the study's conclusions. We advocate for reconciled analyses and future longitudinal studies to enhance patient-centered hypertrophic cardiomyopathy management.</div></div>\",\"PeriodicalId\":29726,\"journal\":{\"name\":\"International Journal of Cardiology Cardiovascular Risk and Prevention\",\"volume\":\"27 \",\"pages\":\"Article 200504\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cardiology Cardiovascular Risk and Prevention\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772487525001424\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cardiology Cardiovascular Risk and Prevention","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772487525001424","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 0

摘要

本文对2025年Tsenov等人关于肥厚性心肌病的研究进行了批评，强调了报告的症状负担、心理支持、就业影响、诊断延迟、活动限制和药物耐受性方面的差异。最近的证据表明，新疗法和综合护理可以改善结果，这对研究结论提出了挑战。我们提倡调和分析和未来的纵向研究，以加强以患者为中心的肥厚性心肌病管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Addressing discrepancies in symptom and psychosocial assessments in hypertrophic cardiomyopathy

This correspondence critiques a 2025 study by Tsenov et al. on hypertrophic cardiomyopathy, highlighting discrepancies in reported symptom burden, psychological support, employment impact, diagnostic delays, activity restrictions, and medication tolerability. Recent evidence suggests improved outcomes with novel therapies and integrated care, challenging the study's conclusions. We advocate for reconciled analyses and future longitudinal studies to enhance patient-centered hypertrophic cardiomyopathy management.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International Journal of Cardiology Cardiovascular Risk and Prevention Cardiology and Cardiovascular Medicine

CiteScore

3.00

自引率

0.00%

发文量

审稿时长

72 days